Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 13, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 138
- +5 vs. Q1 2021
- Portfolio value
- $4.39B
- −$330.6M (−7.0%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| WWWW International, Inc. | COM | 14,818,300 | $535.5M | 12.2% | 00.0% | Unchanged | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 71,178,364 | $326.7M | 7.4% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 850,000 | $291.7M | 6.6% | 00.0% | Unchanged | History |
| SEERSeer, Inc. | COM CL A | 5,588,366 | $183.2M | 4.2% | 00.0% | Unchanged | History |
| XLRNAcceleron Pharma Inc | COM | 1,400,000 | $175.7M | 4.0% | 00.0% | Unchanged | History |
| ARGXArgenx SE | SPONSORED ADR | 500,000 | $150.5M | 3.4% | +50,000+11.1% | Added | History |
| MRTXMirati Therapeutics, Inc. | COM | 850,000 | $137.3M | 3.1% | +125,000+17.2% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 750,000 | $127.1M | 2.9% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 1,350,000 | $117.2M | 2.7% | +50,000+3.8% | Added | History |
| RUBYRubius Therapeutics, Inc. | COM | 4,633,791 | $113.1M | 2.6% | −250,000−5.1% | Reduced | History |
| MORFMorphic Holding, Inc. | COM | 1,819,186 | $104.4M | 2.4% | 00.0% | Unchanged | History |
| IGMSIGM Biosciences, Inc. | COM | 1,100,000 | $91.5M | 2.1% | −25,000−2.2% | Reduced | History |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $75.7M | 1.7% | 00.0% | Unchanged | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 750,000 | $63.0M | 1.4% | 00.0% | Unchanged | History |
| SDGRSchrodinger, Inc. | COM | 797,445 | $60.3M | 1.4% | 00.0% | Unchanged | History |
| SRRKScholar Rock Holding Corp | COM | 2,000,000 | $57.8M | 1.3% | 00.0% | Unchanged | History |
| SAGESage Therapeutics, Inc. | COM | 1,000,000 | $56.8M | 1.3% | +350,000+53.8% | Added | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 2,000,000 | $51.2M | 1.2% | −500,000−20.0% | Reduced | History |
| KLRSKalaris Therapeutics, Inc. | COM | 2,323,371 | $45.9M | 1.0% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 500,000 | $41.2M | 0.9% | +100,000+25.0% | Added | History |
| NTLAIntellia Therapeutics, Inc. | COM | 250,000 | $40.5M | 0.9% | 00.0% | Unchanged | History |
| DNLIDenali Therapeutics Inc. | COM | 500,000 | $39.2M | 0.9% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 400,000 | $38.8M | 0.9% | +400,000 | New | History |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $36.7M | 0.8% | +1,500,000 | New | History |
| FOLDAmicus Therapeutics, Inc. | COM | 3,750,000 | $36.1M | 0.8% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 900,000 | $34.6M | 0.8% | +100,000+12.5% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 500,000 | $34.0M | 0.8% | 00.0% | Unchanged | History |
| AGENAgenus Inc | COM NEW | 6,000,000 | $32.9M | 0.7% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 1,317,954 | $31.6M | 0.7% | 00.0% | Unchanged | History |
| TGTXTG Therapeutics, Inc. | COM | 800,000 | $31.0M | 0.7% | −700,000−46.7% | Reduced | History |
| TRMLTourmaline Bio, Inc. | COM | 2,064,262 | $30.3M | 0.7% | +2,064,262 | New | History |
| VERVVerve Therapeutics, Inc. | COM | 500,000 | $30.1M | 0.7% | +500,000 | New | History |
| DRNADicerna Pharmaceuticals Inc | COM | 800,000 | $29.9M | 0.7% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $27.3M | 0.6% | −25,000−4.8% | Reduced | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 350,000 | $27.3M | 0.6% | +37,300+11.9% | Added | History |
| ITOSiTeos Therapeutics, Inc. | COM | 994,047 | $25.5M | 0.6% | −100,000−9.1% | Reduced | History |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,000,000 | $24.9M | 0.6% | 00.0% | Unchanged | History |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 2,500,000 | $24.3M | 0.6% | 00.0% | Unchanged | – |
| CARAvis Budget Group, Inc. | COM | 300,000 | $23.4M | 0.5% | −150,000−33.3% | Reduced | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,500,000 | $23.3M | 0.5% | −500,000−25.0% | Reduced | History |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $23.2M | 0.5% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $22.1M | 0.5% | 00.0% | Unchanged | – |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $22.1M | 0.5% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $21.9M | 0.5% | +450,000+60.0% | Added | History |
| IMAImageneBio, Inc. | COM | 1,549,513 | $21.8M | 0.5% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $21.5M | 0.5% | +700,000 | New | History |
| ALBOAlbireo Pharma, Inc. | COM | 600,000 | $21.1M | 0.5% | 00.0% | Unchanged | History |
| NGNovagold Resources Inc | COM NEW | 2,600,000 | $20.8M | 0.5% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $20.1M | 0.5% | 00.0% | Unchanged | History |
| NEXINexImmune, Inc. | COM | 1,200,000 | $19.6M | 0.4% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 2,358,968 | $19.2M | 0.4% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $18.4M | 0.4% | 00.0% | Unchanged | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 1,000,000 | $17.9M | 0.4% | +200,000+25.0% | Added | History |
| APTXAptinyx Inc. | COM | 6,116,493 | $17.3M | 0.4% | 00.0% | Unchanged | History |
| RPTXRepare Therapeutics Inc. | COM | 550,000 | $17.1M | 0.4% | 00.0% | Unchanged | History |
| BBIOBridgeBio Pharma, Inc. | COM | 275,000 | $16.8M | 0.4% | +25,000+10.0% | Added | History |
| RNACCartesian Therapeutics, Inc. | COM | 4,000,000 | $16.7M | 0.4% | −500,000−11.1% | Reduced | History |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 850,000 | $16.7M | 0.4% | +850,000 | New | History |
| MRSNMersana Therapeutics, Inc. | COM | 1,200,000 | $16.3M | 0.4% | 00.0% | Unchanged | History |
| ZYMEZymeworks Inc. | COM | 450,000 | $15.6M | 0.4% | 00.0% | Unchanged | History |
| IQiQIYI, Inc. | SPONSORED ADS | 1,000,000 | $15.6M | 0.4% | −25,000−2.4% | Reduced | History |
| DLOdLocal Ltd | CLASS A COM | 295,000 | $15.5M | 0.4% | +295,000 | New | History |
| Bellus Health Inc New07987C204 | COM NEW | 4,750,000 | $14.8M | 0.3% | 00.0% | Unchanged | – |
| RLAYRelay Therapeutics, Inc. | COM | 400,000 | $14.6M | 0.3% | 00.0% | Unchanged | History |
| LFSTLifeStance Health Group, Inc. | COM | 500,000 | $13.9M | 0.3% | +500,000 | New | History |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $13.9M | 0.3% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $13.8M | 0.3% | 00.0% | Unchanged | History |
| Translate Bio, Inc.89374L104 | COM | 500,000 | $13.8M | 0.3% | −500,000−50.0% | Reduced | – |
| EVLOEvelo Biosciences, Inc. | COM | 1,000,000 | $13.7M | 0.3% | 00.0% | Unchanged | History |
| ADAGAdagene Inc. | ADS | 1,000,000 | $13.6M | 0.3% | +200,000+25.0% | Added | History |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $13.5M | 0.3% | 00.0% | Unchanged | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $13.0M | 0.3% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 600,000 | $12.5M | 0.3% | 00.0% | Unchanged | History |
| TCRRTCR2 Therapeutics Inc. | COM | 750,000 | $12.3M | 0.3% | 00.0% | Unchanged | History |
| AGLagilon health, inc. | COM | 300,000 | $12.2M | 0.3% | +300,000 | New | History |
| KYMRKymera Therapeutics, Inc. | COM | 250,000 | $12.1M | 0.3% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $11.4M | 0.3% | +700,000 | New | History |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $11.0M | 0.3% | 00.0% | Unchanged | History |
| KRSAKorsana Biosciences, Inc. | COM | 2,779,122 | $10.8M | 0.2% | +961,538+52.9% | Added | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $10.5M | 0.2% | +600,000+25.0% | Added | History |
| CRISCuris Inc | COM NEW | 1,300,000 | $10.5M | 0.2% | −504,729−28.0% | Reduced | History |
| VORVor Biopharma Inc. | COM | 550,000 | $10.3M | 0.2% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 500,000 | $9.89M | 0.2% | +500,000 | New | History |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $9.78M | 0.2% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 1,700,000 | $9.27M | 0.2% | +675,000+65.9% | Added | History |
| BPMCBlueprint Medicines Corp | COM | 100,000 | $8.80M | 0.2% | +100,000 | New | History |
| YI111, Inc. | ADS | 966,349 | $8.78M | 0.2% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM | 450,000 | $8.69M | 0.2% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 700,000 | $8.58M | 0.2% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $8.41M | 0.2% | 00.0% | Unchanged | History |
| APLTApplied Therapeutics, Inc. | COM | 400,000 | $8.31M | 0.2% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM | 2,250,000 | $8.23M | 0.2% | 00.0% | Unchanged | History |
| DSGNDesign Therapeutics, Inc. | COM | 400,000 | $7.96M | 0.2% | 00.0% | Unchanged | History |
| ACIUAC Immune SA | SHS | 1,000,000 | $7.93M | 0.2% | 00.0% | Unchanged | History |
| ORTXOrchard Therapeutics plc | ADS | 1,803,858 | $7.92M | 0.2% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 400,000 | $7.86M | 0.2% | 00.0% | Unchanged | History |
| ARAVAravive, Inc. | COM | 1,311,291 | $7.84M | 0.2% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $7.81M | 0.2% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $7.46M | 0.2% | 00.0% | Unchanged | – |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 200,000 | $7.32M | 0.2% | 00.0% | Unchanged | History |
Options (6)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q1 2021 (14)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| BNTXBioNTech SE | SPONSORED ADS | 900,000 | $98.3M | 2.1% | History |
| INTCIntel Corp | Stock | 800,000 | $51.2M | 1.1% | History |
| ChemoCentryx, Inc.16383L106 | COM | 750,000 | $38.4M | 0.8% | – |
| AVGOBroadcom Inc. | Stock | 75,000 | $34.8M | 0.7% | History |
| BEKEKE Holdings Inc. | SPONSORED ADS | 600,000 | $34.2M | 0.7% | History |
| CPNGCoupang, Inc. | CL A | 400,000 | $19.7M | 0.4% | History |
| ZZillow Group, Inc. | CL C CAP STK | 100,000 | $13.0M | 0.3% | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 400,000 | $12.7M | 0.3% | History |
| TMETencent Music Entertainment Group | SPON ADS | 550,000 | $11.3M | 0.2% | History |
| TCOMTrip.com Group Ltd | ADS | 250,000 | $9.91M | 0.2% | History |
| GDSGDS Holdings Ltd | SPONSORED ADS | 100,000 | $8.11M | 0.2% | History |
| SHLSShoals Technologies Group, Inc. | CL A | 100,000 | $3.48M | 0.1% | History |
| PTGXProtagonist Therapeutics, Inc | COM | 75,000 | $1.94M | <0.1% | History |
| MANUManchester United plc | ORD CL A | 12,488 | $197.0K | <0.1% | History |